|  Help  |  About  |  Contact Us

Publication : MicroRNA-146a-deficient mice develop immune complex glomerulonephritis.

First Author  Amrouche L Year  2019
Journal  Sci Rep Volume  9
Issue  1 Pages  15597
PubMed ID  31666653 Mgi Jnum  J:284210
Mgi Id  MGI:6389286 Doi  10.1038/s41598-019-51985-1
Citation  Amrouche L, et al. (2019) MicroRNA-146a-deficient mice develop immune complex glomerulonephritis. Sci Rep 9(1):15597
abstractText  MicroRNAs (miRNAs) play an important role in the kidneys under physiological and pathological conditions, but their role in immune glomerulonephritis is unclear. miR-146a has been identified as a key player in innate immunity and inflammatory responses, and in the kidney, this miRNA is involved in the response of injured tubular cells. We studied the renal and immune phenotypes of miR-146a(+/+) and miR-146a(-/-) mice at 12 months of age, and the results showed that miR-146a(-/-) mice developed autoimmunity during aging, as demonstrated by circulating antibodies targeting double-stranded DNA and an immune complex-mediated glomerulonephritis associated with a mild renal immune infiltrate. In addition, miR-146a(-/-) mice showed reduced expression of the transmembrane protein Kim1/Tim1, a key regulator of regulatory B cell (Breg) homeostasis, in the kidney and the immune cells. The numbers of memory B cells and plasmablasts were increased in miR-146a(-/-) mice compared with the numbers in wild-type mice, whereas Bregs were decreased in number and displayed an altered capacity to produce IL-10. Finally, we showed that miR-146a(-/-) mice develop an autoimmune syndrome with increasing age, and this syndrome includes immune complex glomerulonephritis, which might be due to altered B cell responses associated with Kim1/Tim1 deficiency. This study unravels a link between miR-146a and Kim1 and identifies miR-146a as a significant player in immune-mediated glomerulonephritis pathogenesis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression